CSP
ALKS icon

Cary Street Partners’s Alkermes ALKS Stock Holding History

Cary Street Partners’s Portfolio ALKS Stock Details ALKS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289K Buy
+5,520
New +$216K 0.01% 815

Other funds holding ALKS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Cary Street Partners's ALKS Position: Q2 2026 in Review

Cary Street Partners opened a new position in Alkermes (ALKS) in Q2 2026: 5,520 shares worth $289K. The stake represents 0.01% of the portfolio and ranks #815 among its holdings.

424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

  • Cary Street Partners held 5,520 shares of Alkermes worth $289K as of Q2 2026.
  • Alkermes was a new Cary Street Partners position in Q2 2026.
  • Alkermes made up 0.01% of Cary Street Partners's portfolio in Q2 2026, its #815 holding.
  • 424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on Cary Street Partners's 13F filing for Q2 2026, filed 17 Jul 2026.